Strides Pharma Science Limited (NSE:STAR)
1,083.00
+7.00 (0.65%)
Jul 10, 2026, 3:29 PM IST
Strides Pharma Science Market Cap
Strides Pharma Science has a market cap or net worth of 99.79 billion as of July 10, 2026. Its market cap has increased by 28.09% in one year.
Market Cap
99.79B
Enterprise Value
115.65B
Revenue
48.59B
Ranking
n/a
PE Ratio
17.94
Stock Price
1,083.00
Market Cap Chart
Since February 2, 2000, Strides Pharma Science's market cap has increased from 7.49B to 99.79B, an increase of 1,231.55%. That is a compound annual growth rate of 10.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 99.79B | 20.24% |
| Dec 31, 2025 | 82.99B | 36.56% |
| Dec 31, 2024 | 60.77B | 1.87% |
| Dec 29, 2023 | 59.66B | 88.83% |
| Dec 30, 2022 | 31.59B | -21.29% |
| Dec 31, 2021 | 40.14B | -49.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eris Lifesciences | 198.15B |
| NATCO Pharma | 172.23B |
| Cohance Lifesciences | 168.39B |
| Alembic Pharmaceuticals | 159.47B |
| Alivus Life Sciences | 140.28B |
| Akums Drugs and Pharmaceuticals | 100.77B |
| Sudeep Pharma | 90.62B |
| Sun Pharma Advanced Research Company | 90.08B |